Compare Gerdau S.A. Common Stock (GGB) vs Halozyme Therapeutics Inc. Common Stock (HALO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Gerdau S.A. Common Stock vs Halozyme Therapeutics Inc. Common Stock — how do they compare? Gerdau S.A. Common Stock trades at $5.14 (market cap $9.16B), while Halozyme Therapeutics Inc. Common Stock trades at $110.59 (market cap $12.58B). The key difference: Halozyme Therapeutics Inc. Common Stock is the larger of the two by market cap, and Gerdau S.A. Common Stock pays a 3.67% dividend while Halozyme Therapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Gerdau S.A. Common Stock for 1 Days and Halozyme Therapeutics Inc. Common Stock for 1 Days on average.
| GGB | HALO | |
|---|---|---|
Market Cap | $9.16B | $12.58B |
Volume | 16,238,936 | 2,179,278 |
Sector | Basic Materials | Health |
52-Week High | $5.17 | $115.22 |
52-Week Low | $3.15 | $61.63 |
Typical Hold Time | 1 Days | 1 Days |
Enterprise Value | $11.10B | $14.49B |
Dividend Yield | 3.67% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Gerdau S.A. Common Stock
Gerdau is a steel producer with operations across the Americas. It makes long steel, specialty steel, and other products for construction and industrial markets.
Read more on GGB →About Halozyme Therapeutics Inc. Common Stock
Halozyme Therapeutics develops drug-delivery technologies for biopharmaceutical companies. Its ENHANZE technology uses the rHuPH20 enzyme to support subcutaneous delivery of co-administered medicines.
Read more on HALO →
